ID	Database	Citation
16672367	Pubmed	"Carrier EJ, Auchampach JA, Hillard CJ. Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression. Proc Natl Acad Sci U S A. 2006 May 16;103(20):7895–900. <a href=""http://www.ncbi.nlm.nih.gov/pubmed/16672367"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/16672367"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/16672367"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
21704641	Pubmed	"Jiang R, Yamaori S, Takeda S, Yamamoto I, Watanabe K. Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes. Life Sci. 2011 Aug 1;89(5–6):165–70. <a href=""http://www.ncbi.nlm.nih.gov/pubmed/21704641"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/21704641"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/21704641"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
23108542	Pubmed	"Díaz-Alonso J, Guzmán M, Galve-Roperh I. Endocannabinoids via CB₁ receptors act as neurogenic niche cues during cortical development. Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3229–41. <a href=""http://www.ncbi.nlm.nih.gov/pubmed/23108542"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/23108542"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/23108542"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
26187180	Pubmed	"Yamaori S, Kinugasa Y, Jiang R, Takeda S, Yamamoto I, Watanabe K. Cannabidiol induces expression of human cytochrome P450 1A1 that is possibly mediated through aryl hydrocarbon receptor signaling in HepG2 cells. Life Sci. 2015 Sep 1;136:87–93. <a href=""http://www.ncbi.nlm.nih.gov/pubmed/26187180"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/26187180"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/26187180"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
26218440	Pubmed	"Laprairie RB, Bagher AM, Kelly MEM, Denovan-Wright EM. Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor. Br J Pharmacol. 2015 Oct;172(20):4790–805. <a href=""http://www.ncbi.nlm.nih.gov/pubmed/26218440"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/26218440"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/26218440"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
27106177	Pubmed	"Anderson GD, Chan L-N. Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products. Clin Pharmacokinet. 2016 Nov;55(11):1353–68. <a href=""http://www.ncbi.nlm.nih.gov/pubmed/27106177"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/27106177"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/27106177"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
